290 related articles for article (PubMed ID: 28181494)
1. Microenvironment-derived factors driving metastatic plasticity in melanoma.
Kim IS; Heilmann S; Kansler ER; Zhang Y; Zimmer M; Ratnakumar K; Bowman RL; Simon-Vermot T; Fennell M; Garippa R; Lu L; Lee W; Hollmann T; Xavier JB; White RM
Nat Commun; 2017 Feb; 8():14343. PubMed ID: 28181494
[TBL] [Abstract][Full Text] [Related]
2. Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma.
Falletta P; Sanchez-Del-Campo L; Chauhan J; Effern M; Kenyon A; Kershaw CJ; Siddaway R; Lisle R; Freter R; Daniels MJ; Lu X; Tüting T; Middleton M; Buffa FM; Willis AE; Pavitt G; Ronai ZA; Sauka-Spengler T; Hölzel M; Goding CR
Genes Dev; 2017 Jan; 31(1):18-33. PubMed ID: 28096186
[TBL] [Abstract][Full Text] [Related]
3. RNA-seq Characterization of Melanoma Phenotype Switch in 3D Collagen after p38 MAPK Inhibitor Treatment.
Čermák V; Škarková A; Merta L; Kolomazníková V; Palušová V; Uldrijan S; Rösel D; Brábek J
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33802847
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines.
Noguchi K; Dalton AC; Howley BV; McCall BJ; Yoshida A; Diehl JA; Howe PH
PLoS One; 2017; 12(5):e0177830. PubMed ID: 28545079
[TBL] [Abstract][Full Text] [Related]
5. Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing.
Miskolczi Z; Smith MP; Rowling EJ; Ferguson J; Barriuso J; Wellbrock C
Oncogene; 2018 Jun; 37(23):3166-3182. PubMed ID: 29545604
[TBL] [Abstract][Full Text] [Related]
6. Deciphering Melanoma Cell States and Plasticity with Zebrafish Models.
Travnickova J; Patton EE
J Invest Dermatol; 2021 Jun; 141(6):1389-1394. PubMed ID: 33340501
[TBL] [Abstract][Full Text] [Related]
7. The Wnts of change: How Wnts regulate phenotype switching in melanoma.
Webster MR; Kugel CH; Weeraratna AT
Biochim Biophys Acta; 2015 Dec; 1856(2):244-51. PubMed ID: 26546268
[TBL] [Abstract][Full Text] [Related]
8. Cellular Reprogramming-A Model for Melanoma Cellular Plasticity.
Granados K; Poelchen J; Novak D; Utikal J
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167306
[TBL] [Abstract][Full Text] [Related]
9. Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities.
Rambow F; Marine JC; Goding CR
Genes Dev; 2019 Oct; 33(19-20):1295-1318. PubMed ID: 31575676
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional signatures underlying dynamic phenotypic switching and novel disease biomarkers in a linear cellular model of melanoma progression.
Pessoa DO; Rius FE; Papaiz DD; Ayub ALP; Morais AS; de Souza CF; da Paixão VF; Setubal JC; Newton-Bishop J; Nsengimana J; Azevedo H; Reis EM; Jasiulionis MG
Neoplasia; 2021 Apr; 23(4):439-455. PubMed ID: 33845354
[TBL] [Abstract][Full Text] [Related]
11. Phenotype Switching and the Melanoma Microenvironment; Impact on Immunotherapy and Drug Resistance.
Hossain SM; Eccles MR
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675114
[TBL] [Abstract][Full Text] [Related]
12. Plasticity of melanoma cells induced by neural cell crest conditions and three-dimensional growth.
Ghislin S; Deshayes F; Lauriol J; Middendorp S; Martins I; Al-Daccak R; Alcaide-Loridan C
Melanoma Res; 2012 Jun; 22(3):184-94. PubMed ID: 22454190
[TBL] [Abstract][Full Text] [Related]
13. Inflammation-Induced Plasticity in Melanoma Therapy and Metastasis.
Hölzel M; Tüting T
Trends Immunol; 2016 Jun; 37(6):364-374. PubMed ID: 27151281
[TBL] [Abstract][Full Text] [Related]
14. Genetic screening for single-cell variability modulators driving therapy resistance.
Torre EA; Arai E; Bayatpour S; Jiang CL; Beck LE; Emert BL; Shaffer SM; Mellis IA; Fane ME; Alicea GM; Budinich KA; Weeraratna AT; Shi J; Raj A
Nat Genet; 2021 Jan; 53(1):76-85. PubMed ID: 33398196
[TBL] [Abstract][Full Text] [Related]
15. GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells.
Javelaud D; Alexaki VI; Pierrat MJ; Hoek KS; Dennler S; Van Kempen L; Bertolotto C; Ballotti R; Saule S; Delmas V; Mauviel A
Pigment Cell Melanoma Res; 2011 Oct; 24(5):932-43. PubMed ID: 21801332
[TBL] [Abstract][Full Text] [Related]
16. Inhibitor of DNA Binding 4 (ID4) is highly expressed in human melanoma tissues and may function to restrict normal differentiation of melanoma cells.
Peretz Y; Wu H; Patel S; Bellacosa A; Katz RA
PLoS One; 2015; 10(2):e0116839. PubMed ID: 25642713
[TBL] [Abstract][Full Text] [Related]
17. Tumor cell plasticity in uveal melanoma: microenvironment directed dampening of the invasive and metastatic genotype and phenotype accompanies the generation of vasculogenic mimicry patterns.
Folberg R; Arbieva Z; Moses J; Hayee A; Sandal T; Kadkol S; Lin AY; Valyi-Nagy K; Setty S; Leach L; Chévez-Barrios P; Larsen P; Majumdar D; Pe'er J; Maniotis AJ
Am J Pathol; 2006 Oct; 169(4):1376-89. PubMed ID: 17003493
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells.
Cheli Y; Giuliano S; Fenouille N; Allegra M; Hofman V; Hofman P; Bahadoran P; Lacour JP; Tartare-Deckert S; Bertolotto C; Ballotti R
Oncogene; 2012 May; 31(19):2461-70. PubMed ID: 21996743
[TBL] [Abstract][Full Text] [Related]
19. Role of microphthalmia transcription factor (Mitf) in melanoma differentiation.
Lekmine F; Chang CK; Sethakorn N; Das Gupta TK; Salti GI
Biochem Biophys Res Commun; 2007 Mar; 354(3):830-5. PubMed ID: 17266927
[TBL] [Abstract][Full Text] [Related]
20. Lysosomal acid ceramidase ASAH1 controls the transition between invasive and proliferative phenotype in melanoma cells.
Leclerc J; Garandeau D; Pandiani C; Gaudel C; Bille K; Nottet N; Garcia V; Colosetti P; Pagnotta S; Bahadoran P; Tondeur G; Mograbi B; Dalle S; Caramel J; Levade T; Ballotti R; Andrieu-Abadie N; Bertolotto C
Oncogene; 2019 Feb; 38(8):1282-1295. PubMed ID: 30254208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
